FDA approved first generic of drug used to treat severe hypoglycemia
On Dec. 28, 2020, the FDA approved the first generic of glucagon for injection USP, 1 mg/vial packaged…
On Dec. 28, 2020, the FDA approved the first generic of glucagon for injection USP, 1 mg/vial packaged…
On Dec. 28, 2020, Soligenix announced that the National Institute of Allergy and Infectious Diseases (NIAID), had awarded…
On Dec. 24, 2020, AIM ImmunoTech announced that the post-COVID-19 モLong Haulerï¾” portion of the active AMP-511 Expanded…
On Dec. 23, 2020, Merck announced an agreement with the U.S. Government to support the development, manufacture and…
On Dec. 23, 2020, Serum Institute of India and Dynavax jointly announced that the first participants had been…
On Dec. 23, 2020, VBI Vaccines announced that the European Medicines Agency (EMA) has accepted the filing of…
On Dec. 23, 2020, Altimmune announced that the FDA had issued a clinical hold on the Companyï¾’s Investigational…
On Dec. 23, 2020, Tonix Pharmaceuticals announced that it had completed the purchase of an approximately 44-acre site…
On Dec. 23, 2020, Pfizer and BioNTech announced a second agreement with the U.S. government to supply an…
On Dec. 22, 2020, Resverlogix announced published findings in the Proceedings of the National Academy of Sciences (PNAS),…
On Dec. 22, 2020, the NIH researchers announced they had isolated a set of promising, tiny antibodies, or…
On Dec. 22, 2020, the NIH researchers announced that three clinical trial platforms working together to test the…
On Dec. 22, 2020, Abivax announced that the Companyï¾’s ongoing ABX464 phase 2b/3 trial in high-risk Covid-19 patients…
On Dec. 22, 2020, a phase II clinical trial of a treatment for COVID-19 patients was started at…
On Dec. 22, 2020, the ACIP updated interim vaccine allocation recommendations. In Phase 1b, COVID-19 vaccine should be…
On Dec. 1, 2020, the governmenrt of Singapore announced that it had given U.S. start-up Eat Just the…
On Dec. 21, 2020, CureVac announced that the first participant in a clinical Phase 3 study with its…
On Dec. 21, 2020, CVS Health announced it had formally launched its COVID-19 vaccination program for long-term care…
On Dec. 21, 2020, the NIH announced that it had awarded over $107 million to support new, non-traditional…
On Dec. 21, 2020, the NIH announced that it had awarded eight research grants to develop approaches for…
On Dec. 21, 2020, the NIH announced a study published in Proceedings of the National Academy of Sciences…
On Dec. 21, 2020, Innovation Pharma announced that the FDA had approved the Companyï¾’s Investigational New Drug (IND)…
On Dec. 21, 2020, Innovation Pharmaceuticals announced that the FDA had approved the Companyï¾’s Investigational New Drug (IND)…
On Dec. 21, 2020, LabCorp and Walgreens announced that the Pixel by Labcorpï¾™ At-Home COVID-19 Collection Kit is…
On Dec. 21, 2020, Novan announced it had entered into a Master Services Agreement (MSA) with Catalent, which…
On Dec. 21, 2020, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Dec. 21, 2020, Pfizer and BioNTech announced that the European Commission (EC) had granted a conditional marketing…
On Dec. 21, 2020, OraSure Technologies disclosed that the FDA had requested additional information as part of its…
On Dec. 18, 2020, the FDA approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System,…
On Dec. 18, 2020, tthe U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult…